The blood glucose fluctuation difference between weekly GH replacement and daily GH replacement

Not Applicable

Recruiting

• Conditions: Adult grwoth hormone deficiency; pituitary disorder, growth hormone; D010900

• Registration Number: JPRN-jRCT1031210321
• Lead Sponsor: Miyatsuka Takeshi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-09-16
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

The patients who undertake Daily GH replacement (norditropin, humatrope, genotropin, growject) from the Hospital director's permission date by March 31 st, 2023 are going to undergo sogroya.
The administration condition of GH preparation is limited to patients diagnosed with severe adult growth hormone deficiency. Diagnosis of adult growth hormone deficiency (AGHD) as per Japanese practice

Exclusion Criteria

Before undertaking operations or presence of severe trauma.
Presence of malignant tumor(s).
Pregnant or likely to get pregnant.
Diabetes mellitus.
age: less than 20 years old or more than 60 years old

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparing the difference in MAGE between Daily GH replacement and weekly GH replacement.

Secondary Outcome Measures

Name	Time	Method
Comparing the difference in HbA1c, GA, fasting glucose between Daily GH replacement and weekly GH replacement.<br>Comparing the difference in the body composition between Daily GH replacement and weekly GH replacement.